Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
cyclophilin inhibitor .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word alisporivir.
Examples
-
American Fertility Association to educate gay and lesbian community on gestational surrogacy Debiopharm Group signs exclusive licence agreement with Novartis for alisporivir >
THE MEDICAL NEWS Editors 2010
-
USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza KineMed, Bristol-Myers Squibb broaden collaboration to develop novel mechanisms for Alzheimer's disease Debiopharm Group signs exclusive licence agreement with Novartis for alisporivir Advanced paternal age increases autism risk only when the mother is younger Doctors do not follow evidence-based guidelines for treating low back pain, says report NIH awards over $15M for Tulane University's collaborative effort to combat VHF
THE MEDICAL NEWS Editors 2010
-
USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza KineMed, Bristol-Myers Squibb broaden collaboration to develop novel mechanisms for Alzheimer's disease Debiopharm Group signs exclusive licence agreement with Novartis for alisporivir Advanced paternal age increases autism risk only when the mother is younger Doctors do not follow evidence-based guidelines for treating low back pain, says report NIH awards over $15M for Tulane University's collaborative effort to combat VHF
THE MEDICAL NEWS Editors 2010
-
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the signature of an exclusive licence agreement with Novartis for the development, manufacture and commercialisation of Debio 025 (alisporivir), a selective, first-in-class cyclophilin (Cyp) inhibitor with a potent anti-hepatitis C virus (HCV) effect.
THE MEDICAL NEWS Editors 2010
-
USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza KineMed, Bristol-Myers Squibb broaden collaboration to develop novel mechanisms for Alzheimer's disease Debiopharm Group signs exclusive licence agreement with Novartis for alisporivir Advanced paternal age increases autism risk only when the mother is younger Doctors do not follow evidence-based guidelines for treating low back pain, says report NIH awards over $15M for Tulane University's collaborative effort to combat VHF
THE MEDICAL NEWS Editors 2010
-
USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza KineMed, Bristol-Myers Squibb broaden collaboration to develop novel mechanisms for Alzheimer's disease Debiopharm Group signs exclusive licence agreement with Novartis for alisporivir Advanced paternal age increases autism risk only when the mother is younger Doctors do not follow evidence-based guidelines for treating low back pain, says report NIH awards over $15M for Tulane University's collaborative effort to combat VHF
THE MEDICAL NEWS Editors 2010
-
USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza KineMed, Bristol-Myers Squibb broaden collaboration to develop novel mechanisms for Alzheimer's disease Debiopharm Group signs exclusive licence agreement with Novartis for alisporivir Advanced paternal age increases autism risk only when the mother is younger Doctors do not follow evidence-based guidelines for treating low back pain, says report NIH awards over $15M for Tulane University's collaborative effort to combat VHF
THE MEDICAL NEWS Editors 2010
-
Basel - Novartis has gained exclusive rights to develop and market Debio 025 (alisporivir),
-
USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza KineMed, Bristol-Myers Squibb broaden collaboration to develop novel mechanisms for Alzheimer's disease Debiopharm Group signs exclusive licence agreement with Novartis for alisporivir Advanced paternal age increases autism risk only when the mother is younger Doctors do not follow evidence-based guidelines for treating low back pain, says report NIH awards over $15M for Tulane University's collaborative effort to combat VHF
THE MEDICAL NEWS Editors 2010
-
USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza KineMed, Bristol-Myers Squibb broaden collaboration to develop novel mechanisms for Alzheimer's disease Debiopharm Group signs exclusive licence agreement with Novartis for alisporivir Advanced paternal age increases autism risk only when the mother is younger Doctors do not follow evidence-based guidelines for treating low back pain, says report NIH awards over $15M for Tulane University's collaborative effort to combat VHF
THE MEDICAL NEWS Editors 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.